Is Ehlers‑Danlos syndrome, especially the vascular type (type III), associated with intracranial (brain) aneurysms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Ehlers-Danlos syndrome, particularly the vascular type (Type IV), is definitively associated with intracranial aneurysms and carries significant risk of rupture.

Patients with vascular Ehlers-Danlos syndrome (Type IV) should be strongly considered for screening with noninvasive imaging (CTA or MRA) for intracranial aneurysms, especially if there is a family history of intracranial aneurysms or hemorrhagic stroke 1.

The Evidence for Association

The American Heart Association/American Stroke Association guidelines explicitly identify Type IV Ehlers-Danlos syndrome as one of the genetic syndromes associated with increased risk of aneurysmal subarachnoid hemorrhage 1. This is not a theoretical concern—the association is well-established enough to warrant formal screening recommendations in major clinical guidelines.

Quantifying the Risk

Recent systematic review data demonstrates the substantial burden of intracranial aneurysms in EDS:

  • 165 out of 720 vessel-specific aneurysms (23%) occurred in the intracranial region across all EDS subtypes 2
  • The head and neck region represents one of two primary foci for aneurysm formation in EDS patients 2
  • In 27 of 65 patients with ruptured aneurysms, the rupture was the initial presentation of EDS—meaning many patients are undiagnosed until catastrophe strikes 2
  • Multiple aneurysms were present in 163 of 249 systematically evaluated patients, indicating that finding one aneurysm should prompt comprehensive vascular screening 2

Clinical Presentations

Case reports and series confirm that vascular EDS patients present with:

  • Aneurysmal subarachnoid hemorrhage 3, 4
  • Internal carotid artery aneurysms presenting as pulsatile neck masses 5
  • Multiple simultaneous aneurysms in different vascular beds 5

Critical Distinction: Vascular Type vs. Hypermobile Type

Important caveat: The strong association and screening recommendations apply primarily to vascular EDS (Type IV), caused by COL3A1 mutations affecting type III collagen 1.

However, emerging evidence suggests the more common hypermobile EDS (hEDS) may also carry elevated risk:

  • A 2026 study found 10.7% prevalence of unruptured intracranial aneurysms in hEDS/HSD patients presenting to a headache clinic 6
  • Another 2026 study identified aneurysms in 7.3% of hEDS patients undergoing systematic imaging 7

These rates are substantially higher than the general population prevalence of 0.5-6% 8, though the clinical significance and screening implications for hEDS remain under investigation.

Screening Algorithm

For vascular EDS (Type IV):

  1. Strongly consider screening with noninvasive CTA or MRA of the intracranial vessels 1
  2. Screening is particularly indicated if there is also a family history of intracranial aneurysms or hemorrhagic stroke 1
  3. Perform comprehensive vascular imaging from head to pelvis, as multiple aneurysms in different locations are common 2, 9
  4. Establish annual to biannual surveillance imaging once baseline is obtained 9

For hypermobile EDS/HSD:

  • Consider targeted screening with intracranial and cervical arterial imaging, particularly in patients with migraine 6
  • The evidence is emerging but suggests heightened risk compared to general population 7, 6

Surgical Considerations

Critical warning: Vascular fragility in Type IV EDS makes both diagnostic angiography and surgical intervention extremely high-risk:

  • Historical mortality rate of 40% for any vascular surgical procedure in Type IV EDS 10
  • One surgical series reported 25% mortality (1 of 4 patients) from aneurysm surgery due to marked vascular fragility 10
  • Intraoperative and postoperative complications are common even in survivors 10
  • Both open and endovascular approaches carry substantial risk of iatrogenic injury 9

Management priorities:

  • Strict blood pressure control with beta-blockers and angiotensin receptor blockers 9
  • Avoid high-risk medications and activities 9
  • Multidisciplinary team including vascular surgery, genetics, and cardiology 9
  • Surgical intervention only when absolutely necessary, with meticulous technique 10, 9

Key Pitfalls to Avoid

  1. Don't dismiss vascular concerns in non-Type IV EDS: While Type IV carries the highest risk, emerging data suggests hEDS may also warrant screening in select patients 7, 6

  2. Don't stop at finding one aneurysm: Multiple aneurysms are the rule rather than exception—comprehensive vascular imaging is essential 2

  3. Don't underestimate surgical risk: The tissue fragility in vascular EDS makes routine neurovascular procedures life-threatening 10

  4. Don't miss the diagnosis: Aneurysm rupture may be the first presentation of previously undiagnosed EDS 2, 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.